<DOC>
	<DOCNO>NCT01350323</DOCNO>
	<brief_summary>This pilot , prospective , interventional , case-control study investigate aqueous level vascular endothelial growth factor ( VEGF ) eye AMD-related neovascularization treat intravitreal bevacizumab Medical Retina Department , University Molise , Campobasso .</brief_summary>
	<brief_title>Aqueous Vascular Endothelial Growth Factor ( VEGF ) Levels Type 3 Neovascularization</brief_title>
	<detailed_description>This pilot , prospective , interventional , case-control study investigate aqueous level VEGF eye AMD-related NV treat intravitreal bevacizumab . Classification neovascularization base anatomic localization ascertain multimodal image employ FA ( fluorescein angiography ) , ICGA ( indocyanine green angiography ) OCT ( optical coherence tomography ) recently propose Freund et al . Diagnostic procedure follow-up At baseline patient underwent BCVA measurement use early treatment diabetic retinopathy study ( ETDRS ) chart 4 meter , fundus biomicroscopy , FA , ICGA sd-OCT. All examination repeat occasion follow-up appointment exception angiographic test . Angiographic test OCTs scan record use Spectralis sd-OCT ( Spectralis SD-OCT , Heidelberg Engineering , Heidelberg , Germany ) . CMT calculate acquire sequence 145 horizontal section record high-resolution mode ( 1024 A-scans/30 degree ) cover area 20 degree ( horizontal ) × 15 degree ( vertical ) distance ~30 µm individual section . On follow-up examination , image processing software allow reevaluation exactly location . The image process `` Thickness Map '' analysis program . Field 1 map analysis protocol ( central 1 mm ) use central retinal thickness calculation . Aqueous Sampling Bevacizumab Injections All patient AMD-related neovascularization receive three intravitreal injection 1.25 mg/0.05 ml bevacizumab ( Avastin ; Genentech Inc , South San Francisco , California , USA ) baseline , month 1 month 2 . Before injection , topical anesthesia induce tetracaine ( 1 % ) eye drop . Povidone-iodine apply eyelid margin , lash , conjunctiva bulbi fornix . After application sterile drape , lid speculum insert . Immediately intravitreal injection , aqueous sample performed aspirate 0.05-0.1 ml aqueous use 30-gauge needle connect tuberculin syringe temporal limbus . All sample collect operate theatre operate microscope control . Intravitreal bevacizumab ( IVB ) injection perform use 30-gauge needle inferotemporal quadrant 3.5 mm 4 mm posterior limbus . The undiluted aqueous sample transfer sterile container immediately store -80°C freezer analysis . Control Group Reference sample obtain 14 age-matched patient undergo cataract surgery . Aqueous humor sample obtain fashion describe eyes wet-AMD . The undiluted aqueous sample transfer sterile container immediately store -80°C freezer analysis . Vascular Endothelial Growth Factor Assay Collected sample gradually equilibrate room temperature begin assay dilute 1:1 sample diluent provide manufacturer . The VEGF content determine 50 µl dilute sample human VEGF ELISA kit ( EHVEGF , Pierce Biotechnology , Rockford , Illinois , USA ) accord manufacturer 's instruction use extended standard curve include 16 , 8 4 pg/ml standard point . All assay perform duplicate . The minimum detectable concentration VEGF 3.5 pg/ml . Values inferior 3.5pg/ml consider equal 1 statistical analysis .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>wet agerelated macular degeneration type 1 , 2 3 BCVA baseline le 1.0 logMAR previous treatment neovascular lesion previous vitrectomy laser coagulation within last 3 month previous participation study use investigational drug within 3months precede day 0 intraocular surgery ( include cataract surgery ) study eye within 3 month precede day 0 glaucoma study eye ; diabetes mellitus use immunosuppressive drug malignant tumor location</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>